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Abstract 
Acute occlusion of the superior mesenteric artery (SMA) causes extensive bowel necrosis, 
resulting in a poor prognosis with an extremely high mortality rate. An 82-year-old 
woman was admitted to our hospital with the complaint of abdominal pain. She was 
diagnosed as having acute SMA occlusion by enhanced CT. Five hours from onset, the 
first thrombolytic therapy with urokinase was performed, but failed to complete 
thrombolysis and recanalization of peripheral blood flow. An exploratory laparotomy 
following the first thrombolytic therapy showed a mild ischemic change in the affected 
intestine and mesentery, but no sign of necrosis. After the laparotomy, local 
thrombolytic therapy with angiographic evaluation of blood flow at 24, 36 and 48 h from 
the first thrombolysis was performed. As a result, the residual thrombus disappeared and 
all branches of the SMA became well visualized. The patient was discharged well without 
a second-look operation or major bowel resection. Sequential intermittent thrombolytic 
therapy with meticulous angiographic evaluation of blood flow is effective for 
early-stage acute SMA occlusion. 
 
Introduction 
Acute occlusion of the superior mesenteric artery (SMA) causes extensive intestinal 
necrosis due to the difficulty of early diagnosis, resulting in poor prognosis, with a high  
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postoperative mortality rate of 65.2% [1]. Recent reports indicate that selective 
thrombolytic therapy with intraarterial infusion of urokinase is effective for acute SMA 
occlusion diagnosed early after onset [2–6]. Early thrombolytic therapy cannot always 
induce complete thrombolysis, and even if intestinal necrosis is avoided by 
administration of initial thrombolytic therapy, indications for additional thrombolytic 
therapy or the method for monitoring intestinal viability during subsequent follow-up 
have not been established. 
In this report, we present a case of acute SMA occlusion diagnosed early after onset 
that was successfully treated by sequential and intermittent thrombolytic therapy by 
intraarterial urokinase infusion with angiographic evaluation of blood flow, thereby 
avoiding intestinal resection. 
Case Report 
An 82-year-old woman with a past history of atrial fibrillation was admitted to our hospital, 
complaining of acute epigastric pain and stool with fresh blood. Physical examination was as follows: 
blood pressure 140/80, heart rate 70/min, O2 saturation 97% (room air), body temperature 37.2°C. The 
abdomen was flat and soft, with no apparent tenderness or sign of peritoneal irritation. Laboratory data 
on admission revealed an elevated WBC count and mildly elevated hepatic enzyme values (WBC 
15,400/mm
3, CRP 0.05 mg/dl, LDH 502 IU/l, AST 57 IU/l, ALT 21 IU/l, CPK 113 IU/l). Colonoscopy 
revealed mildly erosive, edematous mucosa, but no obvious bleeding from the ascending colon to the 
terminal ileum. Abdominal enhanced CT showed a filling defect in the proximal portion of the SMA 
main trunk, which led to the diagnosis of acute SMA occlusion (fig. 1). Immediately after that diagnosis, 
5 h from onset, selective SMA angiography was performed, showing complete occlusion of the SMA 
around the first jejunal artery branch. Subsequently, intraarterial bolus infusion of urokinase 
(600,000 IU) with thrombus suction was performed. As a result, the thrombus decreased in size and 
peripheral blood flow improved. However, the thrombus remained, and intramural blood flow of the 
affected intestine was not visualized, suggesting possible necrosis of the affected intestine (fig. 2). No 
additional thrombolysis was performed because it would have caused shower embolism. Following the 
first thrombolytic therapy, an exploratory laparotomy was performed. During surgery, a mild ischemic 
change was observed at the intestinal wall from the jejunum 40 cm distal from the Treitz ligament to the 
ascending colon, but no apparent necrosis. Blood flow in the mesentery was well palpable at the central 
portion of the SMA, while peripheral blood flow was not palpable. The operation was completed 
without intestinal resection or direct removal of the thrombus from the SMA. 
Immediately after the laparotomy, intravenous continuous infusion of heparin was started. 24 h after 
the laparotomy, a second angiography was performed via the catheter that remained in place after first 
angiography, because clinical signs such as abdominal pain suggested the progression of intestinal 
ischemia. Peripheral blood flow was well visualized, and no signs of intestinal necrosis were observed. 
Thereafter, thrombolysis with urokinase infusion (240,000 IU) and suction of the residual thrombus 
were performed. In addition, 36 h after the laparotomy, a third angiography and thrombolysis 
(urokinase 240,000 IU) were performed, showing improvement in peripheral blood flow via the gradual 
development of collateral blood flow. Follow-up carefully monitored the possible onset of shower 
embolism by the residual thrombus. Intestinal blood flow was well visualized on CT angiography 
performed 48 h after laparotomy (60 h after the first thrombolytic therapy). The patient began to take 
food by mouth on the 6th day after laparotomy and was discharged from our hospital 35 days after 
laparotomy. She has been free from relapse, receiving anticoagulant therapy with warfarin. 
Discussion 
Early diagnosis and treatment contribute to the improvement of therapeutic results for 
acute SMA occlusion [1]. A delay in diagnosis results in an extremely high mortality rate 
due to extensive intestinal necrosis; however, successful resection of necrotic intestine 
causes short bowel syndrome, severely impairing quality of life. Recent reports indicate 
that enhanced CT is feasible for early diagnosis of acute SMA occlusion. When acute  
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SMA occlusion is suspected from symptom, clinical history and physical findings, 
enhanced CT plays a role not only in identifying the causal portion, but also in 
determining the subsequent treatment plan [3]. Early thrombolytic therapy is effective for 
acute SMA occlusion in avoiding extensive intestinal resection. Since the first report by 
Jamieson et al. [2], reports that support the usefulness of selective thrombolytic therapy 
via a catheter for angiography have increased [3–6]. The ‘golden hour’, the time during 
which the viability of the ischemic intestine can be preserved, varies, dependent on the 
portion and extent of occlusion [7]. Muneoka et al. [3] studied 23 cases of acute SMA 
occlusion treated by selective thrombolytic therapy in Japan, and concluded that the 
golden hour is 5 h for occlusion of the SMA main trunk and 12 h for the occlusion of the 
distal SMA. The goal of thrombolytic therapy is complete thrombolysis, but 
administration over 48 h increases the risk of complication [8]. Easy bleeding due to 
fibrinolysis promoted by urokinase and shower emboli induced by the release of residual 
thrombi are known to be the major complications associated with thrombolytic therapy 
with urokinase. Careful monitoring during 24 h after the completion of thrombolytic 
therapy is essential, and emergency laparotomy is mandatory if intestinal necrosis is 
suspected. Urokinase has no influence during surgery as its half-life in blood is only 
16 min. In the present case, the thrombus was detected in the SMA main trunk by 
angiography performed 5 h from onset. Therefore, judging that we were within the 
golden hour, we added urokinase infusion and thrombus suction via the angiography 
catheter. However, the thrombus remained left, and visualization of intramural blood 
flow was poor, therefore, we selected exploratory laparotomy. 
On the other hand, when no apparent intestinal necrosis is observed during 
exploratory laparotomy, a clinical consensus concerning the indication of additional 
thrombolytic therapy or optimal methods for evaluation of intestinal blood flow or 
viability in the subsequent follow-up is not yet established. Even if intestinal necrosis can 
be avoided, intestinal ischemia would cause perforation or stricture of the affected 
intestine [9, 10]. From 1985 to 2007, 45 cases of thrombolytic therapy for acute SMA 
occlusion were reported in Japan. We studied those 45 cases, which included the present 
case (fig. 3). Of the 45 cases, complete thrombolysis was successful in 28 cases (63.6%), 
and 17 cases (36.4%) received laparotomy following thrombolytic therapy. Among those 
17 patients, intestinal resection was performed in 5 cases (11.1%) due to intestinal 
necrosis; the remaining 12 cases (26.7%) without intestinal necrosis at laparotomy were 
thereafter free from intestinal necrosis. Of those 12 patients, 2 received angiographic 
reevaluation of blood flow and subsequent second-look operation, 3 received 
embolectomy, and 6 were carefully observed by laboratory examination and physical 
findings without any invasive treatments. In the present case, we performed thrombolytic 
therapy with angiographic evaluation of blood flow, sequentially and intermittently, after 
exploratory laparotomy, which enabled us not only to accurately evaluate intestinal blood 
flow or viability, but also to avoid a second-look operation. 
In conclusion, sequential and intermittent thrombolytic therapy with meticulous 
angiographic evaluation of blood flow is effective in the early stage of acute SMA. In 
particular, it is much less invasive than strategies described in previous reports and 
enables accurate evaluation of intestinal blood flow or viability over the time course. 
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Fig. 1. Enhanced CT shows a filling defect at the proximal portion of the SMA main trunk. Arrow 
indicates thrombus. 
 
 
 
Fig. 2. Selective SMA angiography was performed 5 h from onset. Before therapy, the SMA was 
completely occluded by an embolus at the proximal portion (a), and after the bolus infusion of 
urokinase (600,000 IU) into the SMA, peripheral blood flow was improved. However, the thrombus 
decreased in size, but remained (b). Asterisks indicate thrombus. 
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Fig. 3. Forty-five cases of thrombolytic therapy for acute SMA occlusion have been reported in Japan. 
We studied 45 cases including the present case. 
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